- Barron's Meta, Amazon, Apple, Intel, Deckers, Skechers, Clorox, and More Stock Market Movers
- A fight for water intensifies in Spain’s northeast region of Catalonia as officials declare drought emergency
- Malaysia's KLCI index climbs for second session
- Japanese stocks increase as Hang Seng drops
- Thai stocks rally as SET Index gains
- Bond yields steady before payrolls after week of big price gains
- These analysts say the office and apartment building worries after NYCB are like Groundhog Day — but do concede one issue
- Car loaded with gas in Kenya explodes and sets off inferno that injures more than 270, kills at least 33
- Barron's Energy Stocks Have Struggled. Why They Shine as Dividend Payers.
- Barron's Philip Morris Stock Stands to Get a Boost From Earnings
to be replaced
Daiichi Sankyo Co. Ltd.
¥ 4,500
Previous Close |
---|
¥4,650 |
Partner Center
Your Watchlists
Recently Viewed Tickers
Overview
4568 Overview
Key Data
- Open ¥4,604
- Day Range 4,476 - 4,636
- 52 Week Range 3,566 - 5,162
- Market Cap ¥8.48T
- Shares Outstanding 2.13B
- Public Float 1.64B
- Beta 0.87
- Rev. per Employee ¥86.233M
- P/E Ratio 46.41
- EPS ¥97
- Yield 0.89%
- Dividend ¥30
- Ex-Dividend Date Mar 28, 2024
- Short Interest N/A
- % of Float Shorted N/A
- Average Volume 4.39M
Performance
5 Day |
|
1 Month |
|
3 Month |
|
YTD |
|
1 Year |
|
Analyst Ratings
Recent News
Biotech and Pharma Gilead Stock Tumbles on Cancer Drug Disappointment
Biotech and Pharma Buy AstraZeneca Stock. It Looks Much Better Going Into 2024.
Biotech and Pharma Why AstraZeneca Could Be a Sound Long-Term Bet
T. Rowe Price Japan Fund Buys Daiichi Sankyo Co, SoftBank Group Corp, Plaid Inc, Sells Takeda ...
T. Rowe Price Japan Fund Buys Daiichi Sankyo Co, SoftBank Group Corp, Plaid Inc, Sells Takeda Pharmaceutical Co, Welcia Holdings Co
Matthews Japan Fund Buys Yamato Holdings Co, Nissan Chemical Corp, Suntory Beverage & Food, ...
Matthews Japan Fund Buys Yamato Holdings Co, Nissan Chemical Corp, Suntory Beverage & Food, Sells Fanuc Corp, Advantest Corp, Marui Group Co
Daiichi Sankyo Co. Ltd.
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.
Competitors
Name | Chg % | Market Cap |
---|---|---|
Takeda Pharmaceutical Co. Ltd. | ¥6.86T | |
Chugai Pharmaceutical Co. Ltd. | ¥8.79T | |
Shionogi & Co. Ltd. | ¥2.11T | |
Sumitomo Pharma Co. Ltd. | ¥172.43B | |
Hisamitsu Pharmaceutical Co. Inc. | ¥335.17B |